PRCT
PRCT
NASDAQ · Health Care

Procept Biorobotics Corp

$19.20
-1.10 (-5.42%)
As of Nov 7, 1:48 AM ET ·
Financial Highlights (FY 2026)
Revenue
341.14M
Net Income
-105,839,432
Gross Margin
63.7%
Profit Margin
-31.0%
Rev Growth
+60.1%
D/E Ratio
0.14
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.7% 63.7% 37.3% 37.3%
Operating Margin -33.7% -30.3% 12.9% 13.6%
Profit Margin -31.0% -29.5% 13.4% 14.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 341.14M 213.02M 489.54M 398.61M
Gross Profit 217.30M 135.70M 182.63M 148.71M
Operating Income -114,997,603 -64,629,600 62.98M 54.15M
Net Income -105,839,432 -59,482,633 65.46M 56.37M
Gross Margin 63.7% 63.7% 37.3% 37.3%
Operating Margin -33.7% -30.3% 12.9% 13.6%
Profit Margin -31.0% -29.5% 13.4% 14.1%
Rev Growth +60.1% +60.1% +4.3% +1.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 73.02M 73.02M 334.28M 288.62M
Total Equity 517.48M 517.48M 1.05B 1.04B
D/E Ratio 0.14 0.14 0.32 0.28
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -107,936,907 -64,031,510 92.84M 77.63M
Free Cash Flow — — 76.16M 45.47M